The NHS is launching a nationwide programme offering free cholesterol checks at high street pharmacies across England, marking the first time such tests have been available outside clinical settings on this scale. The seven-minute finger-prick blood tests, aimed at people aged 40 to 84, are designed to identify individuals at risk of heart attack or stroke before symptoms appear.
The initiative forms part of a broader ambition to reduce deaths from cardiovascular disease by 25 percent within the next decade, with community pharmacies positioned as a frontline defence in catching these silent health threats early.
A New Frontier in Preventive Care
Under the scheme, eligible adults who have not had a cholesterol test in the past year will be able to walk into participating pharmacies and receive an immediate analysis of their blood lipid levels. A pharmacist prescriber will prick the fingertip using a lancet, analyse the sample on the spot, and provide lifestyle guidance based on the results. Where appropriate, patients may be referred for further treatment, including statins.
Participants will receive their results by email and will also be offered a blood pressure check as part of the consultation. The programme represents a significant shift in how preventive healthcare is delivered, bringing screening services directly into neighbourhood settings rather than requiring patients to visit GP surgeries or hospitals.
David Webb, England’s chief pharmaceutical officer, described pharmacies as a crucial first line of defence. “By making it easier for people to get a quick and convenient cholesterol health check on their local high street, we can spot ticking timebombs earlier, helping people take action, and prevent heart attacks and strokes before they happen,” he said.
Success Story Behind the Pilot
The national rollout follows a successful pilot conducted by Barts Health NHS Trust in collaboration with UCLPartners and the cholesterol charity Heart UK. During the trial in north London, 2,493 patients underwent cholesterol screening. The results were striking: nearly one in five participants were found to be at high risk of experiencing a heart attack or stroke within the following ten years.
Those identified as high-risk were offered advice and referred for treatment. At least 88 individuals subsequently began taking statins as a direct result of the screening. Dr Sotiris Antoniou, clinical lead for the scheme at Barts Health, said scaling this approach across England could transform how pharmacists contribute to cardiovascular prevention.
“By scaling this approach across England, we can support pharmacists to identify cardiovascular risk earlier and, importantly, act on the results through timely advice and treatment,” he explained. “This has the potential to improve outcomes and reduce health inequalities, particularly in communities where the burden of cardiovascular disease is greatest.”
Expanding Access and Reducing Pressure on the NHS
The first phase of the national rollout will see approximately 100 NHS pharmacies across England begin offering the checks from this autumn, with expansion planned in subsequent phases. The announcement was made during the European Society of Cardiology’s annual congress in Munich, the world’s largest gathering of heart specialists.
Health minister Alison McGovern welcomed the initiative, stating it exemplified the kind of innovation the government sought to embed across the health service. “We’re making it easier for people to spot potential problems earlier and take action to protect their health,” she said. “Early detection can help prevent serious conditions such as heart attacks and strokes, helping people stay healthier for longer while reducing pressure on NHS services.”
Dr Rani Khatib, NHS England’s national specialty adviser for cardiovascular disease prevention, urged the public to understand their risk factors. “Everyone should strive to be aware of the most common risk factors for heart disease, including high cholesterol and blood pressure, and know their numbers,” he said. “This initiative will help people manage their risk factors earlier and reduce their risk of having heart attacks or strokes.”
Why it Matters
Cardiovascular disease remains one of the leading causes of death and disability in England, yet many cases are entirely preventable when risk factors are identified and managed early. By bringing cholesterol screening to high street pharmacies, the NHS is dismantling a significant barrier to early detection: access. Millions of people who might never visit a GP surgery for a routine check-up pass their local chemist every day. Making screening free, convenient, and instantaneous transforms the pharmacy from a place people go when they are already ill into a proactive health hub capable of saving lives. The pilot data alone—nearly one in five participants harbouring serious, previously undetected risk—demonstrates the profound public health impact this programme could have if rolled out at scale. As the NHS grapples with mounting pressure on emergency departments and GP services, empowering pharmacists to deliver preventive care represents both a practical necessity and a bold reimagining of community healthcare.
